Huntington's disease: Silencing a brutal killer
- 31 December 2009
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 220 (2) , 226-229
- https://doi.org/10.1016/j.expneurol.2009.09.017
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAsNature Biotechnology, 2009
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease PatientsCurrent Biology, 2009
- Sustained effects of nonallele‐specific Huntingtin silencingAnnals of Neurology, 2009
- A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interferenceExperimental Neurology, 2009
- CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing HaplogroupAmerican Journal of Human Genetics, 2009
- Linking SNPs to CAG repeat length in Huntington's disease patientsNature Methods, 2008
- Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivoNeurobiology of Disease, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Determinants of specific RNA interference-mediated silencing of human β-globin alleles differing by a single nucleotide polymorphismProceedings of the National Academy of Sciences, 2006